Staff Contact: Andrew Wheeler
The Centers for Medicare & Medicaid Services issued a final rule that would give Medicare beneficiaries access to the latest, most advanced devices. CMS states, “Today’s action represents a step forward that will help smooth the Medicare coverage pathway for innovative products, resulting in faster access to new devices for America’s seniors.” The Medicare Coverage of Innovative Technology generally will create national coverage for “breakthrough devices, the services necessary to implant and maintain the devices, and any reasonable and necessary treatments due to complications from the devices.” MCIT will be available only for U.S. Food and Drug Administration-designated breakthrough devises that have been market authorized.